
    
      This was an exploratory study to evaluate the effect of 500 or 1000 mg per day for 8 weeks of
      Rufinamide compared to placebo on measures of anxiety in patients with Generalized Anxiety
      Disorder, and to determine tolerability of Rufinamide in this population.
    
  